The Lancet Respiratory Medicine in conversation with

156 Episodes

1. Inhaled budesonide in the treatment of early COVID-19

   Published: 15/04/2021
2. Tocilizumab and COVID-19

   Published: 5/03/2021
3. Interferon treatment and COVID-19

   Published: 6/02/2021
4. Evaluating deterioration in patients with acute COVID-19

   Published: 12/01/2021
5. Treatment options in patients with systemic sclerosis-associated interstitial lung disease

   Published: 5/01/2021
6. COVID-19 and severe influenza

   Published: 18/12/2020
7. The second wave and homeless populations

   Published: 11/11/2020
8. Corticosteroids, COPD, asthma and COVID-19

   Published: 25/09/2020
9. Novel strategies to drive down the global burden of asthma

   Published: 8/09/2020
10. The pathology of suspected EVALI

    Published: 5/08/2020
11. Wheezing illness and RSV-LRTI

    Published: 17/07/2020
12. Antibiotic use in infancy and asthma incidence

    Published: 16/03/2020
13. Guidance on the development of prediction models for critical care

    Published: 12/03/2020
14. Potential exacerbations in patients with COPD

    Published: 3/03/2020
15. CPAP and mild obstructive sleep apnea

    Published: 28/11/2019
16. An algorithm for EVALI

    Published: 8/11/2019
17. Lung transplants from Hepatitis C viremic donors

    Published: 5/10/2019
18. Looking to the future of cystic fibrosis care

    Published: 29/09/2019
19. Pamrevlumab and idiopathic pulmonary fibrosis

    Published: 27/09/2019
20. Nicotine patches, e-cigarettes, and smoking cessation

    Published: 10/09/2019